Sri Nayana Eye Hospital Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.36 M
- Revenue Growth %
- Profit Growth -7057.04%
- Ebitda -10425.00%
- Net Worth -209.18%
- Total Assets 566.54%
About Sri Nayana Eye Hospital
Sri Nayana Eye Hospital Private Limited (SNEHPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 November 2020 (Four years and three months 8 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹6.36 M.
Divya Malreddy and Sahitya Tatineni serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85300TG2020PTC145710
-
Company No.
145710
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Nov 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sri Nayana Eye Hospital?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Divya Malreddy
|
Director | 07-Nov-2020 | Current |
|
Sahitya Tatineni
|
Director | 07-Nov-2020 | Current |
Financial Performance of Sri Nayana Eye Hospital.
Sri Nayana Eye Hospital Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 7057.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 209.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Nayana Eye Hospital?
Unlock access to Sri Nayana Eye Hospital's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹6.36 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.64 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Mar 2024 | Others | ₹6.36 M | Open |
How Many Employees Work at Sri Nayana Eye Hospital?
Sri Nayana Eye Hospital has a workforce of 13 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Nayana Eye Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Nayana Eye Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.